INS and type 2 diabetes mellitus: The lower SAT TXNIP gene expression levels could therefore be a compensatory mechanism that contributes toward slowing the natural disease process by increasing peripheral glucose uptake and maintaining insulin sensitivity in subjects at increased risk of future T2DM.